ENHANCED LEUKOTRIENE SYNTHESIS IN LEUKOCYTES OF ATOPIC AND ASTHMATIC SUBJECTS

被引:59
作者
SAMPSON, AP [1 ]
THOMAS, RU [1 ]
COSTELLO, JF [1 ]
PIPER, PJ [1 ]
机构
[1] KINGS COLL,SCH MED & DENT,DEPT THORAC MED,LONDON SE5 9PJ,ENGLAND
关键词
LEUKOTRIENES; ATOPIC ASTHMA; LEUKOCYTES; GM-CSF;
D O I
10.1111/j.1365-2125.1992.tb04062.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have investigated the capacities of peripheral leukocytes from atopic asthmatic (AA) (n = 7), atopic non-asthmatic (AN) (n = 7), and normal (N) (n = 7) subjects to generate the bronchoconstrictor and proinflammatory mediators leukotrienes (LTs) B4 and C4. 2 Mixed leukocyte preparations containing 61-84% neutrophils, 2.4-15% eosinophils, and 13-29% mononuclear cells were incubated in vitro at 37-degrees-C in the presence of calcium ionophore A23187. Synthesis of LTB4 and LTC4 was quantitated by radioimmunoassay. 3 Both in dose-response experiments (0-10-mu-M A23187 for 5 min), and in time-course investigations (2-mu-M A23187 for 0-30 min), the mixed leukocytes of the AA and AN subjects generated on average 4- to 5-fold more LTB4 and 3- to 5-fold more LTC4 than the normal leukocytes (P < 0.01 in all cases; ANOVA). 4 This enhanced LT synthesis by the AN and AA leukocytes was not due to differences in the counts of leukocyte sub-types, or to altered rates of LT catabolism between the subject groups. 5 LTB4 synthesis correlated significantly with LTC4 synthesis in the leukocytes of the AN and AA subjects (r = 0.81, n = 14, P < 0.01), but not in those of the normal subjects (r = 0.19, n = 7, P > 0.05). 6 Our results demonstrate an up-regulation of the leukotriene synthetic pathway in the circulating leukocytes of atopic non-asthmatic and atopic asthmatic subjects, which may have important implications in the pathophysiology of asthma and allergy.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 37 条
  • [21] OWEN WF, 1987, J IMMUNOL, V138, P532
  • [22] INTERLEUKIN-5 AND PHENOTYPICALLY ALTERED EOSINOPHILS IN THE BLOOD OF PATIENTS WITH THE IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
    OWEN, WF
    ROTHENBERG, ME
    PETERSEN, J
    WELLER, PF
    SILBERSTEIN, D
    SHEFFER, AL
    STEVENS, RL
    SOBERMAN, RJ
    AUSTEN, KF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) : 343 - 348
  • [23] RADEAU T, 1990, American Review of Respiratory Disease, V141, pA33
  • [24] THE DEVELOPMENT OF SENSITIVE AND SPECIFIC RADIOIMMUNOASSAYS FOR LEUKOTRIENES
    ROKACH, J
    HAYES, EC
    GIRARD, Y
    LOMBARDO, DL
    MAYCOCK, AL
    ROSENTHAL, AS
    YOUNG, RN
    ZAMBONI, R
    ZWEERINK, HJ
    [J]. PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1984, 13 (01): : 21 - 25
  • [25] SAMPSON A P, 1990, Pulmonary Pharmacology, V3, P111, DOI 10.1016/0952-0600(90)90041-G
  • [26] SHAW RJ, 1984, CLIN EXP IMMUNOL, V56, P716
  • [27] SILBERSTEIN DS, 1986, J IMMUNOL, V137, P3290
  • [28] CHARACTERIZATION OF THE NEUTROPHIL RESPIRATORY BURST IN ATOPY
    STYRT, B
    ROCKLIN, RE
    KLEMPNER, MS
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 20 - 26
  • [29] TAYLOR GW, 1989, LANCET, V1, P584
  • [30] EFFECT OF CYSTEINYL-LEUKOTRIENE RECEPTOR ANTAGONIST ICI 204.219 ON ALLERGEN-INDUCED BRONCHOCONSTRICTION AND AIRWAY HYPERREACTIVITY IN ATOPIC SUBJECTS
    TAYLOR, IK
    OSHAUGHNESSY, KM
    FULLER, RW
    DOLLERY, CT
    [J]. LANCET, 1991, 337 (8743) : 690 - 694